Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2013-07-15FDA Approved: LAMOTRIGINE — Original Application (Amneal Pharmaceuticals of New York LLC)
The FDA approved Amneal Pharmaceuticals of New York LLC's original ANDA for lamotrigine, a generic version of the anticonvulsant. The approv…
-
FDA approval · 2013-07-12FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) filed by Sumitomo Pharma America, Inc.
-
CLINICAL_TRIALS trial_result · 2013-07-12Clinical Trial Update: Efficacy of Combined Treatment for Young Bipolar I Disorder [Phase 4]
A Phase 4 clinical trial update reports on the efficacy of a combined treatment approach for young people with Bipolar I Disorder.
-
FDA approval · 2013-07-09FDA Approved: EPITOL — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for EPITOL (carbamazepine) filed by Teva Pharmaceuticals USA, Inc., under ANDA070541.
-
FDA approval · 2013-07-03FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved a supplemental application for Geodon (ziprasidone mesylate) submitted by Viatris Specialty LLC.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2013-07-03FDA Approved: GEODON — Supplemental Application (Viatris Specialty LLC)
FDA approved Viatris Specialty LLC's supplemental application for Geodon (ziprasidone).
-
CLINICAL_TRIALS trial_result · 2013-07-02Clinical Trial Update: Lurasidone - A 6-week Study of Patients With Bipolar I Depression (Monotherapy) [Phase 3]
Phase 3, 6-week monotherapy trial of lurasidone for Bipolar I depression, with results posted.
-
FDA approval · 2013-06-28FDA Approved: LATUDA — Supplemental Application (Sumitomo Pharma America, Inc.)
FDA approved a supplemental application for LATUDA (lurasidone hydrochloride) submitted by Sumitomo Pharma America, Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-28Clinical Trial Update: Effectiveness of Lithium Plus Optimized Medication in Treating People With Bipolar Disorder [Phase 4]
Phase 4 trial update evaluating the effectiveness of lithium with optimized medication in treating bipolar disorder; results posted in 2013.
-
CLINICAL_TRIALS trial_result · 2013-06-27Clinical Trial Update: An Open-Label Trial of Aripiprazole in Children and Adolescents With Bipolar Disorder [Phase 3]
An open-label Phase 3 trial of aripiprazole in children and adolescents with bipolar disorder has completed, with the document providing an …
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Maintenance Therapies in Bipolar Disorders [Phase 3]
A Phase 3 clinical trial update indicating the completion of a maintenance therapy study for Bipolar Disorder. The study is conducted by the…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Effects of Comorbid Personality Disorder on the Treatment of Bipolar I Disorder [Phase 4]
This Phase 4 clinical trial update examines how comorbid Borderline Personality Disorder influences treatment outcomes in patients with Bipo…
-
CLINICAL_TRIALS trial_result · 2013-06-25Clinical Trial Update: Psychosocial Therapy Plus Maintenance Pharmacotherapy for Treating Bipolar Disorder [Phase 4]
Phase 4 clinical trial evaluating psychosocial therapy plus maintenance pharmacotherapy for bipolar disorder has completed.
-
FDA approval · 2013-06-19FDA Approved: LAMOTRIGINE — Original Application (NorthStar Rx LLC)
FDA approved NorthStar Rx LLC's generic Lamotrigine under an Original Application (ANDA) for use in treating epilepsy and bipolar disorder.
-
CLINICAL_TRIALS trial_result · 2013-06-19Clinical Trial Update: Omega-3 Fatty Acids in Children and Adolescents With Bipolar Disorder [NA]
Clinical trial on omega-3 fatty acids in children and adolescents with Bipolar Disorder has completed.
-
CLINICAL_TRIALS research · 2013-06-18Clinical Trial Update: PSYCHE (Personalised Monitoring SYstems for Care in Mental Health)
ClinicalTrials.gov record for the PSYCHE study (Personalised Monitoring Systems for Care in Mental Health) sponsored by University Hospital,…
-
CLINICAL_TRIALS trial_result · 2013-06-17Clinical Trial Update: Efficacy, Safety, and Tolerability of Eslicarbazepine Acetate in the Recurrence Prevention of Bipolar I Disorder [Phase 2]
Phase 2 trial results evaluate the efficacy, safety, and tolerability of eslicarbazepine acetate for preventing recurrence in Bipolar I Diso…
-
FDA label_change · 2013-06-14FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for Depakote (divalproex sodium) submitted by AbbVie, resulting in labeling changes for the prod…
-
FDA approval · 2013-06-14FDA Approved: DEPAKOTE ER — Supplemental Application (AbbVie Inc.)
The FDA approved a supplemental application for DEPAKOTE ER (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2013-06-14FDA Approved: LAMOTRIGINE — Original Application (Ascend Laboratories, LLC)
FDA approves Ascend Laboratories, LLC's original ANDA for lamotrigine, enabling the marketing of a lamotrigine generic product.
-
FDA approval · 2013-06-13FDA Approved: RISPERDAL — Supplemental Application (Janssen Pharmaceuticals, Inc.)
FDA approved a supplemental application for RISPERDAL (risperidone) from Janssen Pharmaceuticals, Inc.
-
FDA approval · 2013-06-13FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine from Sun Pharmaceutical Industries, Inc., indicating an update to the product's re…
-
FDA approval · 2013-06-13FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2013-06-13Clinical Trial Update: Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder [Phase 4]
Open-label Phase 4 trial comparing risperidone, olanzapine, and quetiapine for mania in children and adolescents with Bipolar I or II disord…
-
CLINICAL_TRIALS research · 2013-06-13Clinical Trial Update: Spectroscopy in Children and Adolescents With Bipolar Disorder
This completed clinical trial update describes spectroscopy research in children and adolescents with bipolar disorder, with ADHD listed amo…